yemenjmedYemen Journal of MedicinecoVolume 3 Issue 3MultidisciplinaryEnglishSeptember- December 2024NNY20241215ArticleRecurrent respiratory papillomatosis in a 5-year old child from sokoto, Nigeria: A masquerader of childhood bronchial asthmaEnglishY252256Fatima BelloJiya1EnglishNPaul KehindeIbitoye1EnglishYMaryamAmodu-Sanni1EnglishYIdris AbiodunRufai1EnglishYAli AngoYaroko1EnglishYAbdulmajidUsamatu1EnglishYIdayat AdulrazakAdeyemo1EnglishYMikailu AbubakarJangebe1EnglishYSanusiSaidu1EnglishYBashar MuhammadGoronyo1EnglishYIshaqAbdulwahab1EnglishY10.18231/j.yjom.2024.028Recurrent respiratory papillomatosis (RRP) is a rare, chronic disease caused by the human papilloma virus. A delay in appropriate intervention could be caused by the symptomatology being similar to bronchial asthma. A 5-year-old boy presented to the pediatric emergency unit of Usmanu Danfodiyo University Teaching Hospital with a 2-year history of recurrent difficulty in breathing, cough and noisy breathing. He had previously received several treatments for asthma at Primary Health Care (PHC) facilities. On examination, he was dyspneic with a respiratory rate of 60 cycles/minute, oxygen saturation was 86% on room air, and chest auscultation showed vesicular breath sounds. Initially, acute severe asthma was diagnosed. However, further examination revealed wart-like lesions protruding below the pharynx, and a diagnosis of respiratory papillomatosis was considered. He had an emergency tracheostomy and video-assisted laryngoscopy with excision of the lesions. The histological report confirmed a laryngeal papilloma. His clinical condition improved after removal of wart-like lesions, and he was discharged afterwards. He had three relapses and surgical removal (September and December 2023, June 2024). Currently, he is stable and is being followed up at the Pediatric and Otorhinolaryngology Clinic.EnglishRecurrent Respiratory papillomatosis, childhood, misdiagnosed, Sokotohttps://yemenjmed.com/admin/abstract?id=133References16191. Stephen OA, Adekunle DD. Impediments to clinical diagnosis and management of juvenile onset recurrent respiratory papillomatosis in Ilorin. Nigeria Open J Paediat. 2013;3(2):127and;ndash;32.2. Larson DA, Derkay CS. Epidemiology of recurrent respiratory papillomatosis. APMIS. 2010;118(6-7):450and;ndash;4.3. Afolabi OA, Bature IF, Mainasara MG, Labaran AS, Musa KA, Ghazali BT. Respiratory papillomatosis in northern Nigeria: A 7-year review. Sifa Med J. 2016;3:16and;ndash;20.4. Silverberg MJ, Thorsen P, Lindeberg H, Grant L, Shah KV. Condylomata in pregnancy is strongly predictive of juvenile onset recurrent respiratory papillomatosis.and;nbsp;Obstet Gynaecol.and;nbsp;2006;101(4):645and;ndash;52.5. Alanazi A, Karas AF, Husain IA. Recurrent Respiratoryand;nbsp;Papillomatosis : An Update. Int J Head Neck Surg. 2022;13:1and;ndash;7.6. Giorgi MS, Van Den Heuvel E, Gi TP. Age of onset of recurrent respiratory papillomatosis : a distribution analysis. Clin Otolaryngol. 2016;41(5):448and;ndash;53.7. Buchinsky FJ, Donfack J, Derkay CS, Choi SS, Conley SF, Myer CM. Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis. PLoS One. 2008;3(5):2263.8. Kashima HK, Shah F, Lyles A, Glackin R, Muhammad N, Turner L. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope. 1992;102(1):9and;ndash;13.9. Aliyu D, Yikawe S.and;nbsp; Recurrent respiratory papillomatosis: Management challenges in a tertiary health institution. Int J Med Health Res. 2019;5:55and;ndash;8.10. Green GE, Bauman NM, Smith RJ. Pathogenesis and treatment of juvenile onset recurrent respiratory papillomatosis. Otolaryngol Clin North Am. 2000;33(1):187and;ndash;207.11. Derkay C, Bluher A. Recurrent respiratory papillomatosis. Curr Opin Otolaryngol Head Neck Surg. 2018;26(1):421and;ndash;5.12. Wangu Z, Hsu KK.and;nbsp; Impact of HPV vaccination on ano-genital warts and respiratory papillomatosis.and;nbsp;and;nbsp;and;nbsp;and;nbsp;and;nbsp; Hum Vaccin Immunother. 2016;12(6):1357and;ndash;62.13. Smahelova J, Hamisokova E, Ludvikove V, Vydrova J, Traboulsi J, Vencalek O. Outcomes after Human papillomavirus Vaccination in patients with Recurrent Respiratory Papillomatosis: Nonrandomized Clinical Trial. JAMA Otalaryngol Head Neck Surg. 2022;148(7):654and;ndash; 61.14. Nyirjesy S, Osmundson P, Matrka. Spontaneous regression of Recurrent Respiratory Papillomatosis with HPV Vaccination: A case study. J Voice. 2022;36(4):21and;ndash;5.15. Ruiz R, Balamuth N, Javia LR, Zur KB. Systematic Bevacizumab Treatment for Recurrent Respiratory Papillomatosis: Long-term follow-up. Laryngoscope. 2022;132(10):2071and;ndash;5.16. Din-Lovinescu C, Blitzer A. Metformin for the Treatment of Recurrent Respiratory Papillomatosis Ann. Otol Rhinol Laryngol. 2022;132(8):970and;ndash;5.17. Ablanedo-Terrazas Y, Estrada-Camacho O, Barrera ADL, Ramirez-Garcia C, Tona-Acedo A, Bross-Sorianod G. Efficacy of Cidofovir versus Bevacizumab in recurrent respiratory papillomatosis: A randomized double-blind, placebo-controlled pilot study.and;nbsp;Acta Otorrinolarringol Esp. 2022;73:82and;ndash;8.